Literature DB >> 15574754

Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R.

Akash Nanda1, Phillip Buckhaults, Steven Seaman, Nishant Agrawal, Paula Boutin, Srinivas Shankara, Mariana Nacht, Beverly Teicher, Jason Stampfl, Sujay Singh, Bert Vogelstein, Kenneth W Kinzler, Brad St Croix.   

Abstract

Tumor endothelial marker 7 (TEM7) was recently identified as an mRNA transcript overexpressed in the blood vessels of human solid tumors. Here, we identify several new variants of TEM7, derived by alternative splicing, that are predicted to be intracellular (TEM7-I), secreted (TEM7-S), or on the cell surface membrane (TEM7-M) of tumor endothelium. Using new antibodies against the TEM7 protein, we confirmed the predicted expression of TEM7 on the cell surface and demonstrated that TEM7-M protein, like its mRNA, is overexpressed on the endothelium of various tumor types. We then used an affinity purification strategy to search for TEM7-binding proteins and identified cortactin as a protein capable of binding to the extracellular region of both TEM7 and its closest homologue, TEM7-related (TEM7R), which is also expressed in tumor endothelium. The binding domain of cortactin was mapped to a unique nine-amino acid region in its plexin-like domain. These studies establish the overexpression of TEM7 protein in tumor endothelium and provide new opportunities for the delivery of therapeutic and imaging agents to the vessels of solid tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574754     DOI: 10.1158/0008-5472.CAN-04-2716

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  TEM7 (PLXDC1), a key prognostic predictor for resectable gastric cancer, promotes cancer cell migration and invasion.

Authors:  Zi-Zhen Zhang; Rong Hua; Jun-Feng Zhang; Wen-Yi Zhao; En-Hao Zhao; Lin Tu; Chao-Jie Wang; Hui Cao; Zhi-Gang Zhang
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  PLXDC1 (TEM7) is identified in a genome-wide expression screen of glioblastoma endothelium.

Authors:  Robert M Beaty; Jennifer B Edwards; Kathy Boon; I-Mei Siu; James E Conway; Gregory J Riggins
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

3.  High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma.

Authors:  Bruno Fuchs; Eric Mahlum; Chandralekha Halder; Avudaippan Maran; Michael Yaszemski; Beata Bode; Mark Bolander; Gobinda Sarkar
Journal:  Gene       Date:  2007-05-13       Impact factor: 3.688

4.  Phosphoproteomic profiling reveals vasopressin-regulated phosphorylation sites in collecting duct.

Authors:  Amar D Bansal; Jason D Hoffert; Trairak Pisitkun; Shelly Hwang; Chung-Lin Chou; Emily S Boja; Guanghui Wang; Mark A Knepper
Journal:  J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 10.121

5.  Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma.

Authors:  Chandralekha Halder; Christian Ossendorf; Avudaiappan Maran; Michael Yaszemski; Mark E Bolander; Bruno Fuchs; Gobinda Sarkar
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

6.  Plxdc2 is a mitogen for neural progenitors.

Authors:  Suzanne F C Miller-Delaney; Ivo Lieberam; Paula Murphy; Kevin J Mitchell
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

7.  The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.

Authors:  Richard L Carpenter; Ivy Paw; Hu Zhu; Sherona Sirkisoon; Fei Xing; Kounosuke Watabe; Waldemar Debinski; Hui-Wen Lo
Journal:  Oncotarget       Date:  2015-09-08

8.  The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues.

Authors:  K Gaballah; R Oakley; A Hills; A Ryan; M Partridge
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

9.  Identification of genes differentially expressed in dorsal and ventral chick midbrain during early development.

Authors:  A Chittka; Jn Volff; A Wizenmann
Journal:  BMC Dev Biol       Date:  2009-04-27       Impact factor: 1.978

10.  Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes.

Authors:  Mónica Rivera Díaz; Pablo E Vivas-Mejia
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.